22-25028244-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145206.2(KIAA1671):c.245C>T(p.Pro82Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000307 in 1,551,674 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145206.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIAA1671 | NM_001145206.2 | c.245C>T | p.Pro82Leu | missense_variant | 3/13 | ENST00000358431.8 | NP_001138678.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIAA1671 | ENST00000358431.8 | c.245C>T | p.Pro82Leu | missense_variant | 3/13 | 1 | NM_001145206.2 | ENSP00000351207.3 | ||
KIAA1671 | ENST00000406486.8 | c.245C>T | p.Pro82Leu | missense_variant | 4/14 | 5 | ENSP00000385152.3 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152236Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.000324 AC: 453AN: 1399320Hom.: 0 Cov.: 30 AF XY: 0.000317 AC XY: 219AN XY: 690184
GnomAD4 genome AF: 0.000151 AC: 23AN: 152354Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 28, 2021 | The c.245C>T (p.P82L) alteration is located in exon 1 (coding exon 1) of the KIAA1671 gene. This alteration results from a C to T substitution at nucleotide position 245, causing the proline (P) at amino acid position 82 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at